ERIC CHRISTOFF: Open Payments
NPI 1245287317 · CHICAGO, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,757 in 146 payments from 19 companies in 2025. Trend: 2023 $3,711 · 2024 $3,419 · 2025 $3,757
Food & beverage: $3,757
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company | 49 | $1,325 |
| Theratechnologies Inc. | 15 | $616 |
| Gilead Sciences, Inc. | 26 | $596 |
| Merck Sharp & Dohme LLC | 10 | $261 |
| Amgen Inc. | 8 | $186 |
| Otsuka America Pharmaceutical, Inc. | 7 | $149 |
| Lilly USA, LLC | 7 | $128 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $103 |
| PFIZER INC. | 3 | $73 |
| Napo Pharmaceuticals Inc | 3 | $62 |
Products named: EGRIFTA, DOVATO, CABENUVA, PIFELTRO, RUKOBIA, REXULTI, APRETUDE, OTEZLA.
Industry payments across IL — which companies pay providers there.
